ES8300473A1 - Un metodo de preparacion del antigeno superficial de la hepatitis b. - Google Patents

Un metodo de preparacion del antigeno superficial de la hepatitis b.

Info

Publication number
ES8300473A1
ES8300473A1 ES508742A ES508742A ES8300473A1 ES 8300473 A1 ES8300473 A1 ES 8300473A1 ES 508742 A ES508742 A ES 508742A ES 508742 A ES508742 A ES 508742A ES 8300473 A1 ES8300473 A1 ES 8300473A1
Authority
ES
Spain
Prior art keywords
surface antigen
hepatitis
producing hepatitis
hbsag
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508742A
Other languages
English (en)
Other versions
ES508742A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8300473A1 publication Critical patent/ES8300473A1/es
Publication of ES508742A0 publication Critical patent/ES508742A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DEL ANTIGENO SUPERFICIAL DE LA HEPATITIS B. CONSISTE EN EL DESARROLLO DE CELULAS QUE DESPRENDEN ANTIGENO SUPERFICIAL DE LA HEPATITIS B EN UN MEDIO NUTRIENTE CON UN CULTIVO CELULAR <004>IN VITRO<005> SOBRE UNIDADES CAPILARES DE FIBRAS HUECAS C UN LIMITE DE PESO MOLECULAR DE 10.000 APROXIMADAMENTE. EL DESARROLLO SE EFECTUA EN DOS ETAPAS CONSECUTIVAS, LA PRIMERA A UNA TEMPERATURA ENTRE 35<025>C Y 38<025>C, Y LA SEGUNDA A UNA TEMPERATURA ENTRE 30<025>C Y 34<025>C. >ESTE ANTIGENO TIENE APLICACIONES FARMACOLOGICAS COMO VACUNA CONTRA LA HEPATITIS B.
ES508742A 1981-01-16 1982-01-14 Un metodo de preparacion del antigeno superficial de la hepatitis b. Granted ES508742A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/225,555 US4416986A (en) 1981-01-16 1981-01-16 Methods of producing HBsAg

Publications (2)

Publication Number Publication Date
ES8300473A1 true ES8300473A1 (es) 1982-11-16
ES508742A0 ES508742A0 (es) 1982-11-16

Family

ID=22845332

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508742A Granted ES508742A0 (es) 1981-01-16 1982-01-14 Un metodo de preparacion del antigeno superficial de la hepatitis b.

Country Status (10)

Country Link
US (1) US4416986A (es)
EP (1) EP0056761B1 (es)
JP (1) JPS57141294A (es)
AT (1) ATE6402T1 (es)
CA (1) CA1175745A (es)
DE (1) DE3260046D1 (es)
DK (1) DK15382A (es)
ES (1) ES508742A0 (es)
GR (1) GR74755B (es)
PT (1) PT74246B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US5223428A (en) * 1982-12-14 1993-06-29 Baxter International Inc. Method for in vitro culture of mammalian cells
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
US6309635B1 (en) 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
CA1340581C (en) * 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US6022742A (en) 1986-11-26 2000-02-08 Kopf; Henry B. Culture device and method
JP3117994B2 (ja) * 1990-05-16 2000-12-18 ベイラー・カレツジ・オブ・メデイシン 永久的ヒト肝細胞の細胞系および肝臓補助装置(lad)におけるその使用
AU2900792A (en) * 1991-10-24 1993-05-21 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
US5716404A (en) * 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US6123727A (en) * 1995-05-01 2000-09-26 Massachusetts Institute Of Technology Tissue engineered tendons and ligaments
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US6129761A (en) * 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5741685A (en) * 1995-06-07 1998-04-21 Children's Medical Center Corporation Parenchymal cells packaged in immunoprotective tissue for implantation
AU2003220529B2 (en) * 2002-03-27 2006-09-07 Immunex Corporation Methods for increasing polypeptide production
WO2008038641A1 (fr) * 2006-09-26 2008-04-03 Kyoto University Procédé destiné à permettre la prolifération du virus de l'hépatite, fibre creuse pour cultiver des cellules infectées par le virus de l'hépatite et leur utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US4220725A (en) * 1978-04-03 1980-09-02 United States Of America Capillary cell culture device
PT71739B (en) * 1979-09-04 1982-01-26 Merck & Co Inc Process for preparing a cell culture of hepatitis a virus
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
PT72015B (en) * 1979-11-13 1982-06-20 Merck & Co Inc Process for preparing "invitro" cultures of hepatitis b virus
IE51173B1 (en) * 1980-03-27 1986-10-29 Merck & Co Inc Method of growing hepatitis b surface antigen

Also Published As

Publication number Publication date
ES508742A0 (es) 1982-11-16
GR74755B (es) 1984-07-11
PT74246B (en) 1984-05-29
ATE6402T1 (de) 1984-03-15
PT74246A (en) 1982-02-01
EP0056761B1 (en) 1984-02-29
DK15382A (da) 1982-07-17
US4416986A (en) 1983-11-22
CA1175745A (en) 1984-10-09
JPS57141294A (en) 1982-09-01
DE3260046D1 (en) 1984-04-05
EP0056761A1 (en) 1982-07-28

Similar Documents

Publication Publication Date Title
ES8300473A1 (es) Un metodo de preparacion del antigeno superficial de la hepatitis b.
DE3174765D1 (en) High titer production of hepatitis a virus
EP0619117A3 (en) Acemannan applications.
EP0199343A3 (en) Method for producing microscope slides with delimited reactive fields, and slides made according to the method
FR2657884B1 (fr) Procede pour la preparation du facteur viii humain et d&#39;analogues du facteur viii.
HUT39454A (en) Process for preparing derivatives of glycero-phosphocholine and glycero-phospho-ethanolamine
IL81857A0 (en) In vitro method for producing infective bacterial spores and spore-containing insecticidal compositions
HUT58822A (en) Process for producing cristalline r-h-gm-csf
ES8202059A1 (es) Un metodo de preparacion de antigeno superficial de la hepa-titis b
AU2888089A (en) Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same
IE810688L (en) HBsAg FROM A HEPATOMA
GR3018918T3 (en) Artificial viral envelopes
DE3562900D1 (en) Process for preparing adducts of alcohols, ethers and esters with 1,2-dichlorodifluoroethylene
CA2064774A1 (en) Culture methods for producing activated protein c
SE8605535L (sv) Cellsystem, dess framstellning och anvendning
IL85935A0 (en) Interleukin 3 producing cells and process for preparing interleukin 3
SE9400300D0 (sv) Sätt för tillverkning av klädgalge och klädgalge tillverkad enligt sättet
PL268144A1 (en) Method of &#34;in vitro&#34; growing potato microbulbs
JPS6486895A (en) Production of 3&#39;,5&#39;-cyclicadenylic acid
RU94006778A (ru) Способ получения стеклянного брикета для оптического стекла
GB9022949D0 (en) A novel method for the manufacture of high density multidirectional fibre preforms